ERBIN: Erbb2 Interacting Protein – Structure, Function, and Clinical Relevance

A comprehensive biomedical overview of the ERBIN gene, including its genomic context, expression patterns, associated diseases, and mutational landscape.

Gene Information Card

Symbol ERBIN
Full Name erbb2 interacting protein
Gene Type protein coding
Chromosomal Location 5q12.3
NCBI Gene ID 55914 ncbi.nlm.nih.gov/gene/55914
Ensembl ID ENSG00000112812
UniProt ID Q96RT1
OMIM ID 606944
HGNC ID 15807
Aliases ERBB2IP, LAP2, MGC138211, MGC138213

Description

ERBIN (erbb2 interacting protein) encodes a protein that belongs to the leucine-rich repeat and PDZ domain (LAP) family. It interacts with the receptor tyrosine kinase ERBB2 (HER2) and is involved in cell polarity, signaling, and junction assembly. The gene is located on chromosome 5q12.3 and is widely expressed in normal tissues. Mutations and altered expression of ERBIN have been implicated in cancer, particularly breast cancer, and in developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer ERBIN interacts with ERBB2; loss of ERBIN expression may enhance ERBB2 signaling and promote tumorigenesis PMID: 15616553, 19632184
Colorectal cancer Reduced ERBIN expression correlates with poor prognosis and may affect Wnt/β-catenin signaling PMID: 21502563
Lung cancer ERBIN downregulation associated with increased invasiveness and metastasis PMID: 23382211
Intellectual disability (non-syndromic) Homozygous loss-of-function mutations in ERBIN identified in affected individuals PMID: 28416535

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 14.2 Medium
Heart 8.5 Low
Kidney 12.1 Medium
Liver 6.3 Low
Lung 10.8 Medium
Mammary gland 15.7 Medium
Colon 11.4 Medium
Ovary 9.2 Low
Testis 7.1 Low
Skin 13.0 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 18.5 High expression
HCT116 (colorectal cancer) 14.2 Medium expression
A549 (lung cancer) 11.8 Medium expression
HEK293 (embryonic kidney) 9.3 Low expression
HeLa (cervical cancer) 12.7 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.226C>T (p.Arg76*) Nonsense Rare Loss of function; truncation of PDZ domain
c.1045G>A (p.Gly349Arg) Missense Rare Unknown; possibly damaging
c.1582_1583del (p.Leu528Glufs*2) Frameshift Rare Loss of function; premature stop
c.1A>G (p.Met1?) Start loss Rare Loss of function; no translation initiation
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations lead to truncated or absent protein, reducing ERBB2 binding and disrupting cell polarity.

Gain of Function (GOF)

No gain-of-function mutations have been reported in ERBIN.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ERBIN.

Pathways

ERBB signaling pathway (Reactome: R-HSA-1226099)
Cell junction organization (Reactome: R-HSA-446728)
Developmental biology (Reactome: R-HSA-1266738)

Protein Summary

The ERBIN protein (UniProt Q96RT1) is a 1,371-amino-acid scaffold containing a PDZ domain and multiple leucine-rich repeats. It localizes to the basolateral membrane in epithelial cells and binds to ERBB2 (HER2) via its PDZ domain, modulating receptor signaling and cell polarity. ERBIN also interacts with other proteins such as delta-catenin and p0071, contributing to junctional integrity. Loss of ERBIN expression is observed in several cancers and correlates with poor prognosis.

Related Products

Product name Cat.No. Species Gene ID
ERBIN Knockout HEK293 Cell Line EDJ-KQ2868 Human 55914 Details Get a Quote
ERBIN Knockout A-549 Cell Line EDJ-KQ23900 Human 55914 Details Get a Quote
ERBIN Knockout HCT 116 Cell Line EDJ-KQ23901 Human 55914 Details Get a Quote
ERBIN Knockout HeLa Cell Line EDJ-KQ23902 Human 55914 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: